Growth Metrics

GoodRx Holdings (GDRX) Cash from Operations (2019 - 2026)

GoodRx Holdings' Cash from Operations history spans 7 years, with the latest figure at 32888000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 26.5% to 32888000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 167904000.0, a 8.69% decrease, with the full-year FY2025 number at 167904000.0, down 8.69% from a year prior.
  • Cash from Operations hit 32888000.0 in Q4 2025 for GoodRx Holdings, down from 76023000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for GDRX hit a ceiling of 86862000.0 in Q3 2024 and a floor of 9413000.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 40782350.0 across 5 years, with a median of 38756000.0 in 2021.
  • The widest YoY moves for Cash from Operations: up 411.08% in 2025, down 77.9% in 2025.
  • Tracing GDRX's Cash from Operations over 5 years: stood at 49810000.0 in 2021, then tumbled by 36.0% to 31879000.0 in 2022, then tumbled by 50.22% to 15868000.0 in 2023, then surged by 181.97% to 44743000.0 in 2024, then dropped by 26.5% to 32888000.0 in 2025.
  • Business Quant data shows Cash from Operations for GDRX at 32888000.0 in Q4 2025, 76023000.0 in Q3 2025, and 49580000.0 in Q2 2025.